Expression of NDRG2 in clear cell renal cell carcinoma

Jianjun Ma1, Haifeng Jin, He Wang

  • 1Department of Urology, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.

Insights

NDRG2 expression is significantly reduced in clear cell renal cell carcinoma (CCRCC) tissues and cell lines. This down-regulation suggests NDRG2 may act as a tumor suppressor in CCRCC development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Clear cell renal cell carcinoma (CCRCC) is the most prevalent renal cell carcinoma subtype and a leading cause of cancer mortality.
  • The expression and function of NDRG2 (N-Myc downstream-regulated gene 2) in various cancers, including CCRCC, are not fully understood.

Purpose of the Study:

  • To investigate the expression patterns of NDRG2 in CCRCC tissues and cell lines.
  • To determine the potential role of NDRG2 in the carcinogenesis and progression of CCRCC.

Main Methods:

  • Immunohistochemistry and immunofluorescence were used to evaluate NDRG2 protein expression and localization in patient tissues.
  • RT-PCR and Western blot analyses were performed to assess NDRG2 mRNA and protein levels in CCRCC tissues and cell lines.
  • Expression levels were compared between tumor tissues, adjacent non-tumor tissues, and normal renal cell lines.

Main Results:

  • NDRG2 protein was primarily localized in the cytoplasm and membrane of renal carcinoma cells.
  • NDRG2 expression was significantly lower in CCRCC tissues (30.3%) compared to normal renal tissues (91.67%).
  • NDRG2 mRNA and protein levels were down-regulated in CCRCC tissues and cell lines compared to non-cancerous counterparts.

Conclusions:

  • NDRG2 expression is significantly reduced in clear cell renal cell carcinoma.
  • The down-regulation of NDRG2 suggests it may function as a tumor suppressor in the development and progression of CCRCC.